The treatment of depression in general practice: a comparison of L-tryptophan, amitriptyline, and a combination of L-tryptophan and amitriptyline with placebo

scientific article

The treatment of depression in general practice: a comparison of L-tryptophan, amitriptyline, and a combination of L-tryptophan and amitriptyline with placebo is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1017/S0033291700049047
P698PubMed publication ID7156248

P2093author name stringMcQueen JK
Yates CM
Thomson J
Ashcroft GW
Rankin H
Cummings SW
P2860cites workDepressive Illness in a General Practice. A Demographic Study and a Controlled Trial of ImipramineQ54288068
Amine Precursors and DepressionQ66891826
Amitriptyline plasma concentration and clinical responseQ66904585
Plasma Tryptophan Concentration in Depressive Illness and ManiaQ67437906
Letter: Tryptophan and depressionQ67474841
The Comparative Antidepressant Value of L-Tryptophan and Imipramine With and Without Attempted Potentiation by LiothyronineQ69158742
l-Tryptophan in affective disorders: Indoleamine changes and differential clinical effectsQ69330802
Treatment of depression in general practiceQ69499660
Studies of Alpha-methyl-para-tyrosine, L-dopa, and L-tryptophan in Depression and ManiaQ69926431
Sequential comparison of L-tryptophan with E.C.T. in severe depressionQ70134580
Plasma concentration of amitriptyline and clinical responseQ93723513
A rating scale for depressionQ24564540
Multiple Range and Multiple F TestsQ26778372
Metabolism of an oral tryptophan load. I: Effects of dose and pretreatment with tryptophanQ34519645
Tryptophan-nicotinamide, imipramine and their combination in depression. A controlled studyQ34552567
Letter: Tryptophan/imipramine in depressionQ39354850
Amitriptyline plasma-concentration and clinical effect. A World Health Organisation Collaborative StudyQ39471857
Affective disorder: studies with amine precursorsQ41066531
Amitriptyline plasma levels and therapeutic responseQ44990657
The daily rhythm of plasma tryptophan and tyrosine in depressionQ48418035
Total and free tryptophan concentration in the plasma of depressive patientsQ48643863
Potentiation of the antidepressant action of clomipramine by tryptophanQ51290103
Comparative trial of L-tryptophan and amitriptyline in depressive illnessQ51290187
Controlled trial of amitriptyline in general practice.Q51326588
A specific gas-chromatographic method for the measurement of “steady-state” plasma levels of amitriptyline and nortriptyline in patientsQ52121640
Tryptophan in the treatment of depression.Q53785422
Total and non-bound tryptophan in unipolar illnessQ53801700
Comparative trial of L-tryptophan and E.C.T. in severe depressive illness.Q53995007
P433issue4
P407language of work or nameEnglishQ1860
P921main subjectamitriptylineQ58397
tryptophanQ181003
placeboQ269829
P304page(s)741-751
P577publication date1982-11-01
P1433published inPsychological MedicineQ7256364
P1476titleThe treatment of depression in general practice: a comparison of L-tryptophan, amitriptyline, and a combination of L-tryptophan and amitriptyline with placebo
P478volume12

Reverse relations

cites work (P2860)
Q49063210A double-blind comparison of fluvoxamine, imipramine and placebo in depressed patients
Q51091869A placebo-controlled clinical trial of L-tryptophan in premenstrual dysphoria.
Q38969500Adjunctive 5-Hydroxytryptophan Slow-Release for Treatment-Resistant Depression: Clinical and Preclinical Rationale
Q42454498Alpha-lactalbumin-enriched diets enhance serotonin release and induce anxiolytic and rewarding effects in the rat.
Q24202486Amitriptyline versus placebo for major depressive disorder
Q24239979Antidepressants versus placebo for depression in primary care
Q52877703Antidepressive effect of amitriptyline treatment with plasma drug levels controlled within three different ranges.
Q34155549Anxiety, depression, and insomnia
Q35327958Cancer patients' perspectives on discontinuing depression treatment: the "drop out" phenomenon
Q42764855Childhood mortality after high dose vitamin A
Q34729005Cognitive behavioral therapy and mindfulness-based cognitive therapy for depressive symptoms in patients with diabetes: design of a randomized controlled trial
Q43697742Diagnosis of depression by primary care physicians versus a structured diagnostic interview. Understanding discordance
Q35237343Double-blind placebo-controlled trial of amitriptyline among depressed patients in general practice
Q24187378Drugs versus placebo for dysthymia
Q24246945Drugs versus placebo for dysthymia
Q35823058Edinburgh primary care depression study: treatment outcome, patient satisfaction, and cost after 16 weeks
Q48819884Effects of Tryptophan 2,3-Dioxygenase Inhibitors in the Rat
Q34629445Efficacy and tolerability of tricyclic antidepressants and SSRIs compared with placebo for treatment of depression in primary care: a meta-analysis
Q41483596Evaluation of effect of allopurinol and febuxostat in behavioral model of depression in mice
Q35657945Exogenous Tryptophan Promotes Cutaneous Wound Healing of Chronically Stressed Mice through Inhibition of TNF-α and IDO Activation
Q24678618How to increase serotonin in the human brain without drugs
Q39750057Indoleamines in depression and suicide
Q48376896Inhibition of restraint-induced anorexia by injected tryptophan
Q34011523L-Tryptophan: Basic Metabolic Functions, Behavioral Research and Therapeutic Indications.
Q38157695L-Tryptophan: Biochemical, nutritional and pharmacological aspects
Q33553831Managing depression in primary care
Q33569696Measuring quality of life in patients with depression or anxiety
Q52051208Mental health intervention programs in primary care: their scientific basis
Q71826428Moclobemide Versus Clomipramine in Depressed Patients in General Practice. A Randomized, Double-Blind, Parallel, Multicenter Study
Q77071546Modelling the cost effectiveness of antidepressant treatment in primary care
Q48664579Neurotransmitter-precursor-supplement intervention for detoxified heroin addicts
Q37788635Possible roles of excess tryptophan metabolites in cancer
Q39540950Primary care patients' opinions regarding the importance of various aspects of care for depression
Q36902430Randomised controlled trial comparing problem solving treatment with amitriptyline and placebo for major depression in primary care
Q35608339Recognition and management of depression in general practice: consensus statement
Q41690277Serotonergic systems
Q85889587Solid tryptophan as a pseudoracemate: physicochemical and crystallographic characterization
Q38806660TDO as a therapeutic target in brain diseases
Q40891949The effect of carbohydrates on affect
Q30985038The effectiveness of exercise as an intervention in the management of depression: systematic review and meta-regression analysis of randomised controlled trials
Q43799861The metabolic fate of infused L-tryptophan in men: possible clinical implications of the accumulation of circulating tryptophan and tryptophan metabolites
Q34558852The role of serotonin in human mood and social interaction. Insight from altered tryptophan levels
Q34611434The role of vitamins and minerals in psychiatry
Q90169426Therapeutic Duration and Extent Affect the Effect of Moxibustion on Depression-Like Behaviour in Rats via Regulating the Brain Tryptophan Transport and Metabolism
Q34592227Treatment non-adherence in affective disorders.
Q42764825Treatment of depression in primary care
Q47640895Tryptophan supplementation and serotonin function: genetic variations in behavioural effects.
Q40317269Tryptophan supplementation induces a positive bias in the processing of emotional material in healthy female volunteers
Q36986106Use of tryptophan in combination with other antidepressant treatments: a review
Q67771544Which antidepressant?

Search more.